Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 20.5 EUR 1.76% Market Closed
Market Cap: 20.1B EUR
Have any thoughts about
Bayer AG?
Write Note

Relative Value

The Relative Value of one BAYN stock under the Base Case scenario is 88.56 EUR. Compared to the current market price of 20.5 EUR, Bayer AG is Undervalued by 77%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BAYN Relative Value
Base Case
88.56 EUR
Undervaluation 77%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
81
Median 3Y
1
Median 5Y
1
Industry
2.6
Forward
0.4
vs History
vs Industry
40
Median 3Y
11.4
Median 5Y
-4
Industry
23
Forward
3.9
vs History
98
vs Industry
47
Median 3Y
7.5
Median 5Y
7.5
Industry
17.8
vs History
vs Industry
31
Median 3Y
9.8
Median 5Y
8.9
Industry
25.4
vs History
98
vs Industry
68
Median 3Y
1.3
Median 5Y
1.3
Industry
2.2
vs History
98
vs Industry
67
Median 3Y
1.5
Median 5Y
1.6
Industry
2.8
Forward
1
vs History
98
vs Industry
70
Median 3Y
2.6
Median 5Y
2.8
Industry
5.4
vs History
77
vs Industry
45
Median 3Y
6.3
Median 5Y
6.3
Industry
13.7
Forward
4.6
vs History
17
vs Industry
5
Median 3Y
14
Median 5Y
11
Industry
17.2
Forward
6.7
vs History
98
vs Industry
39
Median 3Y
11.6
Median 5Y
11.5
Industry
16.5
vs History
84
vs Industry
24
Median 3Y
18.3
Median 5Y
17.4
Industry
19.3
vs History
98
vs Industry
74
Median 3Y
0.7
Median 5Y
0.7
Industry
2

Multiples Across Competitors

BAYN Competitors Multiples
Bayer AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Bayer AG
XETRA:BAYN
20.1B EUR 0.4 -15.9 4.8 21.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
DE
Bayer AG
XETRA:BAYN
Average P/E: 33.1
Negative Multiple: -15.9
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top